COVID Corruption Media Articles

Excerpts of Key COVID Corruption Media Articles in Major Media

Below are key excerpts of revealing news articles on COVID corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Coronavirus Information Center.

Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

More than half of the money from the Treasury Department's coronavirus emergency fund for small businesses went to just 5 percent of the recipients, according to data on more than 5 million loans that was released by the government Tuesday evening in response to a Freedom of Information Act request and lawsuit. According to data on the government's Paycheck Protection Program (PPP), about 600 mostly larger companies, including dozens of national chains, received the maximum amount allowed under the program of $10 million. The new data shows more than half of the $522 billion ... went to bigger businesses, and only 28 percent of the money was distributed in amounts less than $150,000. Liz Hempowicz, director of public policy for the nonprofit Project on Government Oversight, said the new data shows how the Trump administration chose to focus its coronavirus relief efforts on helping wealthy organizations at the expense of truly small firms. "The data shows that this program primarily benefited the well-banked and well-lawyered at the expense of the small businesses it was supposed to benefit," Hempowicz said. The newly released data comes after a federal lawsuit filed by The Washington Post and 10 other news organizations under the Freedom of Information Act challenging the SBA's refusal to release records on borrowers and loan amounts. A federal judge ordered the release of the data by Tuesday and the agency did not appeal.

Note: For more along these lines, see concise summaries of deeply revealing news articles on government corruption and the coronavirus from reliable major media sources.

The coronavirus was present in the U.S. weeks earlier than scientists and public health officials previously thought, and before cases in China were publicly identified, according to a new government study published Monday. The virus and the illness that it causes, COVID-19, were first identified in Wuhan, China, in December 2019, but it wasn't until about Jan. 20 that the first confirmed COVID-19 case, from a traveler returning from China, was found in the U.S. However, new findings published in the journal Clinical Infectious Diseases suggest that the coronavirus, known officially as SARS-CoV-2, had infected people in the U.S. even earlier. "SARS-CoV-2 infections may have been present in the U.S. in December 2019, earlier than previously recognized," the authors said. This discovery adds to evidence that the virus was quietly spreading around the world before health officials and the public were aware. It also shows the virus's presence in U.S. communities likely didn't start with the first case identified case in January. Researchers came to this conclusion after the U.S. Centers for Disease Control and Prevention analyzed blood donations collected by the American Red Cross. They found evidence of coronavirus antibodies in 106 out of 7,389 blood donations. The CDC analyzed the blood collected between Dec. 13 and Jan. 17. The presence of antibodies in a person's blood means they were exposed to a virus, in this case the coronavirus.

Note: Explore a revealing article questioning the origin and causes of the coronavirus. Explore serious research suggesting that the influenza pandemic of 1918-19 was not what you think. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

Eriko Kobayashi has tried to kill herself four times. The first time, she was just 22 years old with a full-time job in publishing that didn't pay enough to cover her rent and grocery bills in Tokyo. "I was really poor," said Kobayashi, who spent three days unconscious in hospital after the incident. Now 43, Kobayashi has written books on her mental health struggles and has a steady job at an NGO. But the coronavirus is bringing back the stress she used to feel. "My salary was cut, and I cannot see the light at the end of the tunnel," she said. "I constantly feel a sense of crisis that I might fall back into poverty." Experts have warned that the pandemic could lead to a mental health crisis. Mass unemployment, social isolation, and anxiety are taking their toll on people globally. In Japan, government statistics show suicide claimed more lives in October than Covid-19 has over the entire year to date. The monthly number of Japanese suicides rose to 2,153 in October. As of Friday, Japan's total Covid-19 toll was 2,087, the health ministry said. Japan is one of the few major economies to disclose timely suicide data -- the most recent national data for the US, for example, is from 2018. The Japanese data could give other countries insights into the impact of pandemic measures on mental health. For the 10 years leading up to 2019, the number of suicides had been decreasing in Japan. The pandemic appears to have reversed that trend.

Note: A CDC survey in the U.S. found that one in four teenagers had "seriously considered" suicide in the past 30 days. So which is more damaging, the virus itself or the results of the lockdown policies instituted because of it? For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and health from reliable major media sources.

The actual number of coronavirus infections in the U.S. reached nearly 53 million at the end of September and could be approaching 100 million now, according to a model developed by government researchers. The model, created by scientists at the Centers for Disease Control and Prevention, calculated that the true number of infections is about eight times the reported number, which includes only the cases confirmed by a laboratory test. Preliminary estimates using the model found that by the end of September, 52.9 million people had been infected, while the number of laboratory-confirmed infections was just 6.9 million, the team reported in the Nov. 25 issue of the journal Clinical Infectious Diseases. "This indicates that approximately 84% of the U.S. population has not yet been infected and thus most of the country remains at risk," the authors wrote. Since then, the CDC's tally of confirmed infections has increased to 12.5 million. So if the model's ratio still holds, the estimated total would now be greater than 95 million, leaving about 71% of the population uninfected. The model attempts to account for the fact that most cases of COVID-19 are mild or asymptomatic and go unreported. Scientists used studies looking for people who have antibodies to the coronavirus in their blood – an indication that they were infected at some time – to estimate how many infections went undetected. Some of these antibody studies have suggested that only about one in 10 coronavirus infections is reported.

Note: If this is true, it means the number of deaths compared to number of cases is much lower than has been estimated. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

The announcement this week that a cheap, easy-to-make coronavirus vaccine appeared to be up to 90 percent effective was greeted with jubilation. But since unveiling the preliminary results, AstraZeneca has acknowledged a key mistake in the vaccine dosage received by some study participants, adding to questions about whether the vaccine's apparently spectacular efficacy will hold up under additional testing. Scientists and industry experts said the error and a series of other irregularities and omissions in the way AstraZeneca initially disclosed the data have eroded their confidence in the reliability of the results. The regimen that appeared to be 90 percent effective was based on participants receiving a half dose of the vaccine followed a month later by a full dose; the less effective version involved a pair of full doses. AstraZeneca disclosed in its initial announcement that fewer than 2,800 participants received the smaller dosing regimen, compared with nearly 8,900 participants who received two full doses. Moncef Slaoui, the head of Operation Warp Speed, the U.S. initiative to fast-track coronavirus vaccines, noted another limitation in AstraZeneca's data. On a call with reporters, he suggested that the participants who received the half-strength initial dose had been 55 years old or younger. The fact that the initial half-strength dose wasn't tested in older participants, who are especially vulnerable to Covid-19, could undermine AstraZeneca's case to regulators that the vaccine should be authorized for emergency use.

Note: Learn in this revealing article how vaccine trials are rigged. This article spells out how vaccine makers are above the law and face no consequences for damage from vaccines. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and vaccines from reliable major media sources.

When I called up Chuck Collins on Tuesday afternoon, I found him glued to one of the grimmest new metrics documenting America's economic and social unraveling. Collins is a scholar of inequality at the Institute for Policy Studies, a progressive think tank, and since March he has been tracking how the collective wealth of American billionaires has been affected by the coronavirus pandemic. In previous recessions, Collins said, billionaires were hit along with the rest of us; it took almost three years for Forbes's 400 richest people to recover losses incurred in 2008's Great Recession. But in the coronavirus recession of 2020, most billionaires have not lost their shirts. Instead, they've put on bejeweled overcoats and gloves made of spun gold – that is, they've gotten richer than ever before. On Tuesday, as the stock market soared to a record, Collins was watching the billionaires cross a depressing threshold: $1 trillion. That is the amount of new wealth American billionaires have amassed since March, at the start of the devastating lockdowns that state and local governments imposed to curb the pandemic. On March 18, according to a report Collins and his colleagues published last week, America's 614 billionaires were worth a combined $2.95 trillion. When the markets closed on Tuesday, there were 650 billionaires and their combined wealth was now close to $4 trillion. In the worst economic crisis since the 1930s, American billionaires' wealth grew by a third.

Note: For more along these lines, see concise summaries of deeply revealing news articles on income inequality and the coronavirus from reliable major media sources.

More Americans are going hungry now than at any point during the deadly coronavirus pandemic, according to a Post analysis of new federal data – a problem created by an economic downturn that has tightened its grip on millions of Americans and compounded by government relief programs that expired or will terminate at the end of the year. Experts say it is likely that there's more hunger in the United States today than at any point since 1998, when the Census Bureau began collecting comparable data about households' ability to get enough food. One in 8 Americans reported they sometimes or often didn't have enough food to eat in the past week, hitting nearly 26 million American adults, an increase several times greater than the most comparable pre-pandemic figure. That number climbed to more than 1 in 6 adults in households with children. Nowhere has there been a hunger surge worse than in Houston, with a metro-area population of 7 million people. More than 1 in 5 adults in Houston reported going hungry recently, including 3 in 10 adults in households with children. The growth in hunger rates has hit Hispanic and Black households harder than White ones, a devastating consequence of a weak economy that has left so many people trying to secure food even during dangerous conditions. Yet the hunger crisis seems to have escaped widespread notice in a nation where millions of households have weathered the pandemic relatively untouched.

Note: Meanwhile, as the Washington Post reported on Jan. 1, 2021, "billionaires as a class have added about $1 trillion to their total net worth since the pandemic began." For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and income inequality from reliable major media sources.

Youtube recently banned a video. In the video, Dr. Michael Yeadon said half or even almost all of the tests for COVID are false positives. Youtube banned the video within hours. Perhaps what irked the Big Tech was Yeadon's assertion that the panic over the second or third wave of coronavirus may be unfounded. Yeadon, who had worked as Chief Science Officer for pharmaceutical giant Pfizer for 16 years, went on to say that "this pandemic is fundamentally over." Yeadon argues, citing principles of epidemiology, that a "second wave" of COVID is entirely manufactured. Citing the experience with other recent virus outbreaks - the SARS virus in 2003, and MERS in 2012 - he says that the idea of subsequent waves itself is wrong. Instead, what appears like subsequent waves is actually a single wave occurring in different geographical regions at different points in time. "It is actually multiple single waves affecting geographically distinct populations at different times as the disease spreads. Analyzed individually, each area followed a typical single event," he says about MERS. He gave another blow to the establishment, saying that lockdown did not actually help curb the virus spread. Yeadon cites the now-famous example of Sweden. Covid-19 doomsday preacher Neil Fergusson had said Sweden would see 40,000 deaths by May and 100,000 in later months as it did not lock up people in grids. Yet, Sweden's coronavirus toll is 6,000 as of now.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

The coronavirus might be new, but nature long ago gave humans the tools to recognize it, at least on a microscopic scale: antibodies, Y-shaped immune proteins that can latch onto pathogens and block them from infiltrating cells. Millions of years of evolution have honed these proteins into the disease-fighting weapons they are today. But in a span of just months, a combination of human and machine intelligence may have beaten Mother Nature at her own game. Using computational tools, a team of researchers at the University of Washington designed and built from scratch a molecule that, when pitted against the coronavirus in the lab, can attack and sequester it at least as well as an antibody does. This molecule, called a mini-binder for its ability to glom onto the coronavirus, is petite and stable enough to be shipped en masse in a freeze-dried state. Bacteria can also be engineered to churn out these mini-binders, potentially making them not only effective but also cheap and convenient. Eventually, healthy people might be able to self-administer the mini-binders as a nasal spray, and potentially keep any inbound coronavirus particles at bay. Mini-binders are not antibodies, but they thwart the virus in broadly similar ways. The coronavirus enters a cell using a kind of lock-and-key interaction, fitting a protein called a spike – the key – into a molecular lock called ACE-2, which adorns the outsides of certain human cells. Antibodies made by the human immune system can interfere with this process.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

A great deal of conflicting information has emerged about the immune response that develops in patients who have recovered from Covid-19. The good news is that we are unlikely to be reinfected with Sars-Cov-2 repeatedly until it eventually wipes us all out. Most of the evidence ... shows that the immune response to this is quite typical for an acute viral infection. Initially, the body ramps up high levels of IgG antibodies, but after the infection is cleared, those antibodies drop to a baseline level, which may be below the limit of detection of some serological tests. Most people who recover from Covid-19 have detectable neutralising antibodies months after infection. This suggests that Sars-Cov-2 infection does produce an immune response that is protective, at least for several months. Furthermore, antibodies are not the only important part of the immune system. T-cells are also a key component to the immune response. They come in two flavours: helper T-cells, which coordinate immune responses and facilitate immunological memory, and killer T-cells, which kill infected cells. Previous studies have shown that Sars-Cov-2 infection induces robust T-cell responses. Interestingly, some people who have never had Covid-19 have memory T-cells from prior common-cold coronavirus infections that cross-react with Sars-Cov-2, suggesting that there may be some existing protection in the population. T-cells alone are unlikely to provide complete immune protection, but they are a key contributor to immune memory.

Note: The author of this article, Angela Rasmussen, is a virologist and affiliate of the Georgetown Center for Global Health Science and Security. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

Science is being suppressed for political and financial gain. The pandemic has revealed how the medical-political complex can be manipulated in an emergency - a time when it is even more important to safeguard science. The UK's pandemic response provides at least four examples of suppression of science or scientists. First, the membership, research, and deliberations of the Scientific Advisory Group for Emergencies (SAGE) were initially secret until a press leak forced transparency. The leak revealed inappropriate involvement of government advisers in SAGE. Next, a Public Health England report on covid-19 and inequalities ... was delayed by England's Department of Health. Third, on 15 October, the editor of the Lancet complained that an author of a research paper, a UK government scientist, was blocked by the government from speaking to media because of a "difficult political landscape." Now, a new example concerns the controversy over point-of-care antibody testing for covid-19. Research published this week by The BMJ ... finds that the government procured an antibody test that in real world tests falls well short of performance claims made by its manufacturers. Researchers from Public Health England and collaborating institutions sensibly pushed to publish their study findings before the government committed to buying a million of these tests but were blocked by the health department and the prime minister's office.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in science and the coronavirus from reliable major media sources.

Science is being suppressed for political and financial gain. Covid-19 has unleashed state corruption on a grand scale, and it is harmful to public health. The pandemic has revealed how the medical-political complex can be manipulated in an emergency. Research published this week by The BMJ ... finds that the government procured an antibody test that in real world tests falls well short of performance claims made by its manufacturers. Researchers from Public Health England and collaborating institutions sensibly pushed to publish their study findings before the government committed to buying a million of these tests but were blocked by the health department and the prime minister's office. Public Health England then unsuccessfully attempted to block The BMJ's press release about the research paper. In the US, President Trump's government manipulated the Food and Drug Administration to hastily approve unproved drugs such as hydroxychloroquine and remdesivir. Globally, people, policies, and procurement are being corrupted by political and commercial agendas. The UK's pandemic response relies too heavily on scientists and other government appointees with worrying competing interests, including shareholdings in companies that manufacture covid-19 diagnostic tests, treatments, and vaccines. Government appointees are able to ignore or cherry pick science ... and indulge in anti-competitive practices that favour their own products and those of friends and associates.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and corruption in science from reliable major media sources.

Pfizer is expected to seek federal permission to release its Covid-19 vaccine by the end of November. The vaccine, and likely most others, will require two doses to work, injections that must be given weeks apart. The shots will cause enervating flu-like side effects – including sore arms, muscle aches and fever – that could last days and temporarily sideline some people from work or school. And even if a vaccine proves 90 percent effective ... 1 in 10 recipients would still be vulnerable. That means, at least in the short term, as population-level immunity grows, people can't stop social distancing and throw away their masks. Left out so far ... has been a large-scale plan to communicate effectively about those issues in advance, said Saad Omer, director of the Yale Institute for Global Health. Such broad-based outreach will be necessary in a country where, as of mid-October, only half of Americans said they'd be willing to get a Covid-19 vaccine. "We are asking people to take a vaccine that is going to hurt," said Dr. William Schaffner, a professor of preventive medicine and health policy at Vanderbilt. "There are lots of sore arms and substantial numbers of people who feel crummy, with headaches and muscle pain, for a day or two." Persuading people who experience those symptoms to return in three to four weeks for a second dose – and a second round of flu-like symptoms – could be a tough sell, Schaffner said. A professor of internal medicine and epidemiology at University of Iowa [suggested] that essential workers should be granted three days of paid leave after they're vaccinated.

Important Note: Learn about the serious dangers of these mRNA vaccines through the vitally important information given by Christiane Northrup, MD, in the first five minutes of this revealing video. Dr. Northrup's work has been featured on NBC Nightly News, Good Morning America, Oprah, Dr. Oz, and more. And an informative article in the UK's Independent by another medical doctor states, "There are unique and unknown risks to messenger RNA vaccines, including the possibility that they ... could lead to inflammation and autoimmune conditions."

The chairman and CEO of Pfizer, Albert Bourla, sold $5.6 million worth of stock in the pharmaceutical company on Monday. The sale took place on the same day Pfizer announced that its experimental coronavirus vaccine candidate was found to be more than 90% effective. Bourla's sale of Pfizer stock was part of a trading plan set months in advance. Known as 10b5-1 plans, they essentially put stock trades on autopilot. Executives are supposed to adopt these plans only when they are not in possession of inside information that can affect a company's stock price. On Aug. 19, Bourla implemented his stock-trading plan. The next day, Aug. 20, Pfizer issued a press release ... confirming that Pfizer and its German partner, BioNTech, were "on track to seek regulatory review" for its vaccine candidate. Daniel Taylor, an expert in insider trading ... told NPR that the close timing between the adoption of Bourla's stock plan and the press release looked "very suspicious." "It's wholly inappropriate for executives at pharmaceutical companies to be implementing or modifying 10b5-1 plans the business day before they announce data or results from drug trials," Taylor said. The stock sales by Pfizer's CEO brought to mind similar concerns with another coronavirus vaccine-maker, Moderna. Multiple executives at Moderna adopted or modified their stock-trading plans just before key announcements about the company's vaccine. Those executives have sold tens of millions of dollars in Moderna stock.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and Big Pharma profiteering from reliable major media sources.

The U.S. can expect increased Covid-19 testing, a national mask policy and the possibility of nationwide lockdowns once President-elect Joe Biden takes office Jan. 20. The Biden-Harris campaign laid out a step-by-step plan for addressing the coronavirus pandemic that includes more testing, increasing use of the Defense Production Act to make protective equipment for frontline workers and restoring the U.S. relationship with the World Health Organization. On top of that, Biden says he would establish a U.S. public health jobs corps to "mobilize at least 100,000 Americans across the country" to support contact tracing efforts. Biden has called for national mask requirements, though experts say it's unclear how that would be executed. In an Oct. 23 speech, Biden said he would " go to every governor and urge them to mandate mask wearing in their states." And if that doesn't work, Biden said he would turn to mayors and county executives to institute local mandates. Masks would be required in all federal buildings and interstate transportation systems. Biden would also direct the CDC to provide communities with evidence-based guidance on when to close some business or schools depending on the degree of viral spread. The CDC would be empowered to guide states when to place appropriate restrictions on gathering sizes and when to issue stay-at-home orders.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

With less than 24 hours' notice, President Emmanuel Macron announced his plan to plunge the French into a second national lockdown for at least a month. And if everything I hear and read about the UK is to be believed, this country is heading in the same direction. While Boris Johnson will be the person announcing that catastrophic decision, the measures are being dictated by a small group of scientists who, in my view, have repeatedly got things terribly wrong. The Scientific Advisory Group for Emergencies (Sage) has made three incorrect assumptions which have had, and continue to have, disastrous consequences for people's lives and the economy. Firstly, Sage assumes that the vast majority of the population is vulnerable to infection; second, that only 7 per cent of the population has been infected so far; and third, that the virus causing Covid-19 has a mortality rate of about 1 per cent. Multiple research groups in Europe and the US have shown that around 30 per cent of the population was likely already immune to Covid-19 before the virus arrived. Sage has similarly failed to accurately revise down its estimated mortality rate for the virus. Pre-eminent scientists ... have concluded that the mortality rate is closer to 0.2 per cent. That figure means one in 500 people infected die. When applied to the total number of Covid deaths in the UK (around 45,000), this would imply that approximately 22.5million people have been infected. That is 33.5 per cent of our population – not Sage's 7 per cent calculation.

Note: The author of this article, Dr. Mike Yeadon, is a former Vice President and served as Chief Science Officer of the A&R Research Unit of Pfizer for 16 years. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

After the COVID-19 pandemic forced nonessential businesses to temporarily shut down across Southern California, the Los Angeles Times invited readers to send in the names of businesses in their areas that had failed as a result. [#1] The Awesome Playground was in the first wave of Los Angeles businesses to close as a result of the pandemic, shutting its doors in March. Owner Kay Osorio opened the Awesome Playground in Highland Park 10 years ago. But when the coronavirus crisis began making headlines in Southern California, Osorio knew immediately it could have a devastating effect on her business. Unlike other businesses that have been able to pivot to outdoor-only or remote offerings, "we couldn't come up with another way to deliver our service." [#2] Sasha Jones had just one day in late July to clear out Cuties Coffee before its lease was taken over. "I got an email late Thursday afternoon, like, we need to get what we can out tomorrow, Friday," the Cuties CEO said. For weeks, the threat of closure had loomed over the LGBTQ-owned and -operated coffee shop. Since the closure of the coffee shop, Cuties is continuing to operate without a physical space. [#3] When Alan Abdo negotiated with his landlord to end the lease for Olive Tree Restaurant, he remembers saying, "I can't close fast enough. I'm losing money by the minute." Olive Tree was a thriving, well-known Middle Eastern restaurant in Anaheim right up until the enforced business closures began.

Note: Small businesses have been devastated worldwide by the lockdown, yet most large corporations are thriving and the billionaires are making money hand over fist. So who is really benefitting from these lockdown measures? For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

October was a good month for Gilead Sciences, the giant manufacturer of antivirals. On 8 October, the company inked an agreement to supply the European Union with its drug remdesivir as a treatment for COVID-19–a deal potentially worth more than $1 billion. Two weeks later, on 22 October, the U.S. Food and Drug Administration (FDA) approved remdesivir for use against the pandemic coronavirus SARS-CoV-2 in the United States. Both decisions baffled scientists who have closely watched the clinical trials of remdesivir unfold. At best, one large, well-designed study found remdesivir modestly reduced the time to recover from COVID-19 in hospitalized patients with severe illness. A few smaller studies found no impact of treatment on the disease whatsoever. Then ... the World Health Organization's (WHO's) Solidarity trial showed that remdesivir does not reduce mortality or the time COVID-19 patients take to recover. Both [the] FDA's decision and the EU deal came about under unusual circumstances that gave the company important advantages. FDA never consulted a group of outside experts that it has at the ready to weigh in on complicated antiviral drug issues. The European Union, meanwhile, decided to settle on the remdesivir pricing exactly 1 week before the disappointing Solidarity trial results came out. Gilead, having donated remdesivir to the trial, was informed of the data on 23 September and knew the trial was a bust.

Note: Remdesivir had never been approved by the FDA for use before Oct. 2020, yet was rushed through the approval process, while Nobel-prize winning drug Ivermectin was all but banned, even though there was minimal evidence of harm. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

At least four candidates are near the finish line in the U.S. coronavirus vaccine race. A key point to note, however, is that the vaccine isn't an end-all solution to the pandemic. That's in large part because any inoculations developed now are focused on simply preventing symptoms from arising, rather than blocking out the virus altogether. The latter goal is a secondary endpoint, according to Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. "The primary thing you want to do is that if people get infected, prevent them from getting sick, and if you prevent them from getting sick, you will ultimately prevent them from getting seriously ill," Fauci said. "What I would settle for, and all of my colleagues would settle for, is the primary endpoint to prevent clinically recognizable disease," he said. That level of protection would be the ultimate goal to diffusing the crisis, but is hard to do with companies facing an immediate demand for some sort of solution. While no vaccine is 100% effective, having a majority of the population inoculated and higher percentages of efficacy is the best to hope for. The U.K. is looking at challenge trials, which intentionally infect a smaller group of participants with the virus in an effort to test a vaccine's or treatment's efficacy. Fauci said the U.S. is not anticipating such a move because the rate of spread is so high in the country that it's sufficient enough of an environment to test the vaccine.

Note: This Bloomberg article further shows the vaccines are not designed to stop the virus. Why is the media not doing a better job of informing the public about this. Read also this CNBC article titled "Dr. Fauci says masks, social distancing will still be needed after a Covid-19 vaccine." For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccine issues from reliable major media sources.

The development of the antibody cocktail used to treat President Donald Trump for Covid-19 – which he heralded as a cure for the disease – was funded largely by the U.S. government, yet the Trump administration has apparently failed to set any guarantees that the treatment would be affordable. The biopharmaceutical company Regeneron, led by the two highest paid executives in the industry, received hundreds of millions in public funds during the research and development of the antibody therapy, and now stands to make a killing from its potentially lifesaving treatment. In January ... Regeneron struck an agreement with a division of Department of Health and Human Services known as the Biomedical Advanced Research and Development Authority, or BARDA, to receive up to $81 million for work on antibodies that would prevent Covid-19 from infecting cells by attaching to the spikes on its surface. The two antibodies Regeneron chose were developed using cell lines that were derived from the kidney tissue of an aborted fetus. The January contract [lacks] a standard clause that ensures interventions developed with government funding are available to the public "on reasonable terms." While Trump promised that the government would provide the antibody cocktail to Americans for free, drug pricing efforts say that many people probably won't have access to the treatment at all, let alone at an affordable price. "You have massive public investment, but ... it doesn't benefit public health," [said drug pricing expert Zain Rizvi].

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and Big Pharma profiteering from reliable major media sources.

Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.